ReviewVaccines2025

Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy.

Rui Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.